Advanced Health Intelligence Ltd (AHI)
Advanced Health Intelligence Ltd operates in the Software - Application industry of the Technology sector, headquartered in South Perth, WA, AU. The stock last traded at $1.50, up 0.00% on the session, giving a market capitalisation of $345.8M. On trailing twelve-month figures it carries a trailing P/E of -3.81, a net margin of -1125.7%. Its beta of 1.61 implies it has historically moved more than the broad market.
Advanced Health Intelligence Ltd is an Australian-based company operating internationally, specializing in the development of mobile applications and advanced technological solutions. A cornerstone of its offerings is BodyScan, a patented, proprietary dimensioning technology. This innovative solution empowers users to accurately measure and assess their body dimensions simply by utilizing a smartphone. Beyond BodyScan, the company also provides FaceScan, designed to ascertain vital signs and evaluate risks associated with cardiovascular diseases, heart attacks, and strokes. Additionally, its portfolio includes DermaScan, a specialized dermatological scanning tool. These technologies cater to a diverse array of sectors, including mobile health and telehealth, the life and health insurance industry, fitness and wellness providers, and consumer apparel businesses. Established in 2014 and headquartered in South Perth, Australia, the company has undergone several transformations. It was initially known as MyFiziq Limited before rebranding to Advanced Human Imaging Limited in March 2021, and is now recognized as Advanced Health Intelligence Ltd.
Advanced Health Intelligence Ltd is most often compared with the following Technology names: